Our study identified NCL, a highly abundant and conserved protein, with multiple cellular functions involved in cancer, as a potential novel regulator of splice site selection and a component of the SOS mechanism that is proposed to protect cells from latent splicing that would generate transcripts with PTCs. This evidence concerns the gene NUCLEOLIN and cancer.